A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385

Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues

Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221

TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue

Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310

Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., & Willoughby, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2046 · Cited by 1,033

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

García Rodríguez, L., & Jick, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91843-0 · Cited by 975

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

Langman, M. J. S., Weil, J., Wainwright, P., Lawson, D. H., Rawlins, M. D., Logan, R. F. A., Murphy, M., Vessey, M. P., & Colin-Jones, D. G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90185-6 · Cited by 872

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

Kargman, S., O’Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., & Jothy, S. (1995) · PubMed · Cited by 824

Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.

Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., & Hwang, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35698-9 · Cited by 811

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

DeWitt, D. L., & Smith, W. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1412 · Cited by 596

Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.

Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518

Clinical pharmacology of platelet cyclooxygenase inhibition.

Patrono, C., Ciabattoni, G., Patrignani, P., Pugliese, F., Filabozzi, P., Catella, F., Davì, G., & Forni, L. (1985) · Circulation · doi:10.1161/01.cir.72.6.1177 · Cited by 454

The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.

DeWitt, D. L., el-Harith, E. A., Kraemer, S. A., Andrews, M. J., Yao, E. F., Armstrong, R. L., & Smith, W. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34105-5 · Cited by 429

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., & Otomo, S. (1993) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(93)90018-s · Cited by 344

Regulation of prostaglandin synthase-1 and prostaglandin synthase-2

Herschman, H. R., & Hall, W. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00666095 · Cited by 335

Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme

Yokoyama, C., & Tanabe, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80049-x · Cited by 332

Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.

Chan, C. C., Boyce, S., Brideau, C., Ford-Hutchinson, A. W., Gordon, R., Guay, D., Hill, R. G., Li, C. S., Mancini, J., & Penneton, M. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10713-1 · Cited by 313

Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs

Xie, W., Robertson, D. L., & Simmons, D. L. (1992) · Drug Development Research · doi:10.1002/ddr.430250402 · Cited by 306

Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.

Hempel, S. L., Monick, M. M., & Hunninghake, G. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116971 · Cited by 301

Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.

Gans, K. R., Galbraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E., & Ackerman, N. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12610-4 · Cited by 231

Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs.

Martin, T. R., Mathison, J. C., Tobias, P. S., Letúrcq, D. J., Moriarty, A. M., Maunder, R. J., & Ulevitch, R. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116106 · Cited by 213

Pharmacology of Prostaglandin Endoperoxide Synthase Isozymes‐1 and‐2a

SMITH, W. L., MEADE, E. A., & DWITT, D. L. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb12037.x · Cited by 166

The relative toxicity of nonsteroidal antiinflammatory drugs

Fries, J. F., Williams, C. A., & Bloch, D. A. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341103 · Cited by 149

Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding

Kaufman, D. W., Kelly, J. P., Sheehan, J. E., László, A., Wiholm, B., Alfredsson, L. S., Koff, R. S., & Shapiro, S. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.55 · Cited by 118

Cloning and Expression of Rat Prostaglandin Endoperoxide Synthase (Cyclooxygenase)-2 cDNA

Kennedy, B. P., Chan, C., Culp, S. A., & Cromlish, W. A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2506 · Cited by 111

Pharmacokinetic overview of indomethacin and sustained-release indomethacin

Yeh, K. C. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90510-8 · Cited by 43

EQUIANALGESIC EFFECTS OF PARACETAMOL AND INDOMETHACIN IN RHEUMATOID ARTHRITIS

Seideman, P., & Melander, A. (1988) · Rheumatology · doi:10.1093/rheumatology/27.2.117 · Cited by 39

Electron capture negative ion chemical ionization analysis of arachidonic acid

Hadley, J. S., Fradin, A., & Murphy, R. C. (1988) · Journal of Mass Spectrometry · doi:10.1002/bms.1200150309 · Cited by 35

Selective Inhibitors of Cox-2

O’Neill, G. P., Kennedy, B. P., Mancini, J. A., Kargman, S., Ouellet, M., Yergey, J. A., Falgueyret, J., Cromlish, W. A., Payette, P., Chan, C.-C., et al. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7276-8_16 · Cited by 28

Prostaglandin Endoperoxide Synthases

Vaught, M., & Marnett, L. J. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00028-9 · Cited by 25

CYCLOOXYGENASES 1 AND 2

Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis

Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519

Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs

Langman, M. J. (1999) · JAMA · doi:10.1001/jama.282.20.1929 · Cited by 686

Cyclooxygenase inhibitors – current status and future prospects

Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2

Talley, J. J., Brown, D. L., Carter, J. S., Graneto, M. J., Koboldt, C. M., Masferrer, J. L., Perkins, W. E., Rogers, R. S., Shaffer, A. F., Zhang, Y. Y., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990577v · Cited by 638